GRAPEVINE, Tex.—Patients with the metabolic syndrome and decreased estimated glomerular filtration rate (eGFR) are at increased risk of having peripheral arterial disease (PAD), a study shows.

IMPAIRED BONE mineral metabolism is prevalent in CKD patients, presenting a special challenge for patients and renal health professionals. By stage 5 CKD, an estimated 50% or more of dialysis patients have bone mineral parameters that exceed evidence-based practice guidelines.

GRAPEVINE, Tex.—High levels of uric acid are associated with an increased risk of all-cause and CVD mortality, researchers conclude.

WASHINGTON, D.C.—Patients with an endovascular aneurysm repair (EVAR) should be considered a high-risk group for renal artery interventions and receive closer post-procedure surveillance.

GRAPEVINE, Tex.—Higher levels of 25-hydroxyvitamin D (25 [OH] D) may lower the risk of anemia and elevated C-reactive protein levels may raise the risk, according to new study findings that may explain much of the high prevalence of anemia among individuals with kidney disease, researchers conclude.

STOCKHOLM—Hematide doses administered every four weeks (Q4W) maintains long-term mean hemoglobin levels between 11 and 12 g/dL in CKD patients, and it is well tolerated, according to preliminary data from an ongoing phase II trial.

TORONTO—Nearly one third of women with CKD are taking at least five medications, according to researchers.

STOCKHOLM—More than one third of patients with stage III-IV CKD have restless legs syndrome (RLS), an Italian study found.

GRAPEVINE, Tex.—Higher levels of 25-hydroxyvitamin D (25 (OH) D) may lower the risk of anemia and elevated C-reactive protein levels may raise the risk, according to new study findings that may explain much of the high prevalence of anemia among individuals with kidney disease, researchers conclude.

AMAG Pharmaceuticals, Inc., of Cambridge, Mass., has announced that the FDA has accepted for standard review its New Drug Application (NDA) for ferumoxytol as an IV treatment of iron deficiency anemia in CKD patients.